Skip to main content
Institute for Global Health & Infectious Diseases

2015

 

  1. Rosenberg NE, Pilcher CD, Busch MP, Cohen MS. How can we better identify early HIV infections? Curr Opin HIV AIDS 2015;10:61-8.
  2. Targett G. Phase 3 trial with the RTS,S/AS01 malaria vaccine shows protection against clinical and severe malaria in infants and children in Africa. Evid Based Med 2015;20:9.
  3. Pettifor A, Corneli A, Kamanga G, et al. HPTN 062: A Pilot Randomized Controlled Trial Exploring the Effect of a Motivational-Interviewing Intervention on Sexual Behavior among Individuals with Acute HIV Infection in Lilongwe, Malawi. PLoS One 2015;10:e0124452.
  4. Sellers CJ, Lee H, Chasela C, et al. Reducing lost to follow-up in a large clinical trial of prevention of mother-to-child transmission of HIV: the Breastfeeding, Antiretrovirals and Nutrition study experience. Clinical trials 2015;12:156-65.
  5. Chang TS, Wiener J, Dollard SC, et al. Effect of cytomegalovirus infection on breastfeeding transmission of HIV and on the health of infants born to HIV-infected mothers. AIDS 2015;29:831-6.
  6. Davis NL, Barnett EJ, Miller WC, et al. Impact of Daily Cotrimoxazole on Clinical Malaria and Asymptomatic Parasitemias in HIV-Exposed, Uninfected Infants. Clin Infect Dis 2015.
  7. Widen EM, Bentley ME, Chasela CS, et al. Antiretroviral treatment is associated with iron deficiency in HIV-infected Malawian women that is mitigated with supplementation, but is not associated with infant iron deficiency during 24 weeks of exclusive breastfeeding. J Acquir Immune Defic Syndr 2015.
  8. Ramlal RT, Tembo M, King CC, et al. Dietary patterns and maternal anthropometry in HIV-infected, pregnant Malawian women. Nutrients 2015;7:584-94.
  9. Kim MH, Ahmed S, Hosseinipour MC, et al. The impact of Option B+ on the antenatal PMTCT cascade in Lilongwe, Malawi. J Acquir Immune Defic Syndr 2015.
  10. Ahmed S, Kim MH, Dave AC, et al. Improved identification and enrolment into care of HIV-exposed and -infected infants and children following a community health worker intervention in Lilongwe, Malawi. J Int AIDS Soc 2015;18:19305.
  11. Kumarasamy N, Aga E, Ribaudo HJ, et al. Lopinavir/Ritonavir Monotherapy as Second-line Antiretroviral Treatment in Resource-Limited Settings: Week 104 Analysis of AIDS Clinical Trials Group (ACTG) A5230. Clin Infect Dis 2015;60:1552-8.
  12. LaCourse SM, Chester FM, Matoga M, et al. Implementation of routine counselor-initiated opt-out HIV testing on the adult medical ward at Kamuzu Central Hospital, Lilongwe, Malawi. J Acquir Immune Defic Syndr 2015.
  13. LaCourse SM, Chester FM, Preidis G, et al. Lay-screeners and Use of WHO Growth Standards Increase Case Finding of Hospitalized Malawian Children with Severe Acute Malnutrition. J Trop Pediatr 2015;61:44-53.
  14. O’Shea MS, Rosenberg NE, Hosseinipour MC, et al. Effect of HIV status on fertility desire and knowledge of long-acting reversible contraception of postpartum Malawian women. AIDS Care 2015;27:489-98.
  15. Haddad LB, Feldacker C, Jamieson DJ, et al. Pregnancy Prevention and Condom Use Practices among HIV-Infected Women on Antiretroviral Therapy Seeking Family Planning in Lilongwe, Malawi. PLoS One 2015;10:e0121039.
  16. Ryan J, Hamela G, Chome N, Kabondo C, Hosseinipour M, Tang J. Experiences and beliefs of Malawian women who have delivered with a traditional birth attendant. Int J Gynaecol Obstet 2015;129:38-41.
  17. Kim MH, Ahmed S, Hosseinipour MC, et al. Implementation and Operational Research: The Impact of Option B+ on the Antenatal PMTCT Cascade in Lilongwe, Malawi. J Acquir Immune Defic Syndr 2015;68:e77-83.
  18. Kohler RE, Tang J, Gopal S, et al. High rates of cervical cancer among HIV-infected women at a referral hospital in Malawi. Int J STD AIDS 2015.
  19. Orlov M, Smeaton LM, Kumwenda J, Hosseinipour MC, Campbell TB, Schooley RT. Presence of Plasmodium falciparum DNA in Plasma Does Not Predict Clinical Malaria in an HIV-1 Infected Population. PLoS One 2015;10:e0129519.
  20. Safren SA, Mayer KH, Ou SS, et al. Adherence to Early Antiretroviral Therapy: Results From HPTN 052, a Phase III, Multinational Randomized Trial of ART to Prevent HIV-1 Sexual Transmission in Serodiscordant Couples. J Acquir Immune Defic Syndr 2015;69:234-40.
  21. Rutstein SE, Hosseinipour MC, Kamwendo D, et al. Dried blood spots for viral load monitoring in Malawi: feasible and effective. PLoS One 2015;10:e0124748.
  22. Harrington B, Kyriakos Vorkas C, Kanyama C, Ngoma J, Hoffman I, Hosseinipour MC. Altered mental status is an indicator of mortality and associated with both infectious and non-communicable disease in Lilongwe, Malawi. Trop Doct 2015;45:164-7.
  23. Kantor R, Smeaton L, Vardhanabhuti S, et al. Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical Trial. Clin Infect Dis 2015;60:1541-9.
  24. LaCourse SM, Chester FM, Matoga M, et al. Implementation and Operational Research: Implementation of Routine Counselor-Initiated Opt-Out HIV Testing on the Adult Medical Ward at Kamuzu Central Hospital, Lilongwe, Malawi. J Acquir Immune Defic Syndr 2015;69:e31-5.
  25. Erlandson KM, Taejaroenkul S, Smeaton L, et al. A Randomized Comparison of Anthropomorphic Changes With Preferred and Alternative Efavirenz-Based Antiretroviral Regimens in Diverse Multinational Settings. Open forum infectious diseases 2015;2:ofv095.
  26. Balagopal A, Asmuth DM, Yang WT, et al. Pre-cART Elevation of CRP and CD4+ T-Cell Immune Activation Associated With HIV Clinical Progression in a Multinational Case-Cohort Study. J Acquir Immune Defic Syndr 2015;70:163-71.
  27. Shivakoti R, Yang WT, Gupte N, et al. Concurrent Anemia and Elevated C-Reactive Protein Predicts HIV Clinical Treatment Failure, Including Tuberculosis, After Antiretroviral Therapy Initiation. Clin Infect Dis 2015;61:102-10.
  28. Tenforde MW, Gupte N, Dowdy DW, et al. C-reactive protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settings. PLoS One 2015;10:e0117424.
  29. Shivakoti R, Christian P, Yang WT, et al. Prevalence and risk factors of micronutrient deficiencies pre- and post-antiretroviral therapy (ART) among a diverse multicountry cohort of HIV-infected adults. Clinical nutrition 2015.
  30. Bicanic T, Bottomley C, Loyse A, et al. Toxicity of Amphotericin B deoxycholate-based induction therapy in patients with HIV-associated cryptococcal meningitis. Antimicrob Agents Chemother 2015.
  31. Herce ME, Mtande T, Chimbwandira F, et al. Supporting Option B+ scale up and strengthening the prevention of mother-to-child transmission cascade in central Malawi: results from a serial cross-sectional study. BMC Infect Dis 2015;15:328.
  32. Herce ME, Kalanga N, Wroe EB, et al. Excellent clinical outcomes and retention in care for adults with HIV-associated Kaposi sarcoma treated with systemic chemotherapy and integrated antiretroviral therapy in rural Malawi. J Int AIDS Soc 2015;18:19929.
  33. Gopal S, Liomba NG, Montgomery ND, et al. Characteristics and survival for HIV-associated multicentric Castleman disease in Malawi. J Int AIDS Soc 2015;18:20122.
  34. Montgomery ND, Graham T, Krysiak R, et al. Comparison of eosinophil density in staging bone marrow biopsies from Malawi and the United States. Pathology international 2015.
  35. Kohler RE, Moses A, Krysiak R, Liomba NG, Gopal S. Pathologically confirmed breast cancer in Malawi: a descriptive study: Clinical profile of breast cancer. Malawi Med J 2015;27:10-2.
  36. Gutnik LA, Banda T, Gopal S. Initial Institutional Review Board Approval Process in Malawi. JAMA surgery 2015;150:595.
  37. Rutstein SE, Pettifor AE, Phiri S, et al. Incorporating acute HIV screening into routine HIV testing at sexually transmitted infection clinics and HIV testing and counseling centers in Lilongwe, Malawi. J Acquir Immune Defic Syndr 2015.
  38. Puchalski Ritchie LM, van Lettow M, Hosseinipour MC, et al. The effectiveness of interventions to improve uptake and retention of HIV-infected pregnant and breastfeeding women and their infants in prevention of mother-to-child transmission care programs in low- and middle-income countries: protocol for a systematic review and meta-analysis. Systematic reviews 2015;4:144.
  39. Rosenberg NE, Mtande TK, Saidi F, et al. Recruiting male partners for couple HIV testing and counselling in Malawi’s option B+ programme: an unblinded randomised controlled trial. The lancet HIV 2015;2:e483-91.
  40. Neafsey DE, Juraska M, Bedford T, et al. Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine. New England Journal of Medicine 2015;373:2025-37.
  41. Rutstein SE, Golin CE, Wheeler SB, et al. On the front line of HIV virological monitoring: barriers and facilitators from a provider perspective in resource-limited settings. AIDS Care 2015:1-10.
  42. Barnett B, Gokhale RH, Krysiak R, et al. Prevalence of drug resistant TB among outpatients at an HIV/TB clinic in Lilongwe, Malawi. Trans R Soc Trop Med Hyg 2015;109:763-8.
  43. Palanee-Phillips T, Schwartz K, Brown ER, et al. Characteristics of Women Enrolled into a Randomized Clinical Trial of Dapivirine Vaginal Ring for HIV-1 Prevention. PLoS One 2015;10:e0128857.
  44. White MT, Verity R, Griffin JT, et al. Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial. Lancet Infect Dis 2015;15:1450-8.
  45. Heimlich JB, Chipoka G, Kamthunzi P, et al. Establishing sickle cell diagnostics and characterizing a paediatric sickle cell disease cohort in Malawi. Br J Haematol 2015.
  46. Parkhurst JO, Chilongozi D, Hutchinson E. Doubt, defiance, and identity: Understanding resistance to male circumcision for HIV prevention in Malawi. Soc Sci Med 2015;135:15-22.
  47. Tyson AF, Kendig CE, Mabedi C, Cairns BA, Charles AG. The effect of incentive spirometry on postoperative pulmonary function following laparotomy: a randomized clinical trial. JAMA surgery 2015;150:229-36.
  48. Haac B, Varela C, Geyer A, Cairns B, Charles A. The utility of the Kampala trauma score as a triage tool in a sub-Saharan African trauma cohort. World J Surg 2015;39:356-62.
  49. Tyson AF, Varela C, Cairns BA, Charles AG. Hospital mortality following trauma: an analysis of a hospital-based injury surveillance registry in sub-Saharan Africa. Journal of surgical education 2015;72:e66-72.
  50. Kendig C, Tyson A, Young S, Mabedi C, Cairns B, Charles A. The effect of a new surgery residency program on case volume and case complexity in a sub-Saharan African hospital. Journal of surgical education 2015;72:e94-9.
  51. Gallaher JR, Wildfire B, Mabedi C, Cairns BA, Charles AG. Intentional injury against children in Sub-Saharan Africa: A tertiary trauma centre experience. Injury 2015.
  52. Gallaher JR, Mjuweni S, Cairns BA, Charles AG. Burn care delivery in a sub-saharan african unit: A cost analysis study. Int J Surg 2015;19:116-20.
  53. Gallaher JR, Mjuweni S, Shah M, Cairns BA, Charles AG. Timing of early excision and grafting following burn in sub-Saharan Africa. Burns : journal of the International Society for Burn Injuries 2015;41:1353-9.
  54. Bane M, Kaima R, Mapala S, Cairns B, Charles A. Qualitative evaluation of paediatric burn injury in Malawi: assessing opportunities for injury prevention. Trop Doct 2015.
  55. Charles AG, Samuel JC, Riviello R, et al. Integrating global health into surgery residency in the United States. Journal of surgical education 2015;72:e88-93.
  56. Tang JH, Kaliti C, Bengtson A, et al. Improvement and retention of emergency obstetrics and neonatal care knowledge and skills in a hospital mentorship program in Lilongwe, Malawi. Int J Gynaecol Obstet 2015.
  57. Kohler RE, Lee CN, Gopal S, Reeve BB, Weiner BJ, Wheeler SB. Developing a discrete choice experiment in Malawi: eliciting preferences for breast cancer early detection services. Patient Prefer Adherence 2015;9:1459-72.
  58. Mlombe YB, Rosenberg NE, Wolf LL, et al. Environmental risk factors for oesophageal cancer in Malawi: A case-control study. Malawi Med J 2015;27:88-92.
  59. Rhee SY, Jordan MR, Raizes E, et al. HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance Testing. PLoS One 2015;10:e0145772.